Amelioration of Alzheimer’s disease by neuroprotective effect of sulforaphane in animal model

Regulation of in vitro Aβ1-40 Aggregation Mediated by Small Molecules

(2017) Hye Yun Kim et al.   JOURNAL OF ALZHEIMERS DISEASE

Efficient access to highly pure β-amyloid peptide by optimized solid-phase synthesis

(2012) Ji Won Choi et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

The Safety of Cruciferous Plants in Humans: A Systematic Review

(2012) Ori Scott et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Sulforaphane Activates Heat Shock Response and Enhances Proteasome Activity through Up-regulation of Hsp27

(2010) Nanqin Gan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Repeated transient sulforaphane stimulation in astrocytes leads to prolonged Nrf2-mediated gene expression and protection from superoxide-induced damage

(2010) Petra Bergström et al.   NEUROPHARMACOLOGY

Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution

(2010) Harry Levine   PROTEIN SCIENCE

Protection against amyloid beta cytotoxicity by sulforaphane: Role of the proteasome

(2009) Hyun-Min Park et al.   ARCHIVES OF PHARMACAL RESEARCH

Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options

(2009) Bayani Uttara et al.   Current Neuropharmacology

Multivalent & Multifunctional Ligands to β-Amyloid

(2009) YoungSoo Kim et al.   CURRENT PHARMACEUTICAL DESIGN

Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia

(2009) Cindy M Sondag et al.   Journal of Neuroinflammation

Kavalactones Protect Neural Cells against Amyloid   Peptide-Induced Neurotoxicity via Extracellular Signal-Regulated Kinase 1/2-Dependent Nuclear Factor Erythroid 2-Related Factor 2 Activation

(2008) C. J. Wruck et al.   MOLECULAR PHARMACOLOGY